Cardiovascular: Page 3

RNA biomarkers may help confirm heart disease, study finds

By Elissa Wolfson

RNA analysis of blood from patients with angiographically confirmed coronary artery disease demonstrates how RNA biomarkers may help confirm heart disease.

March 30, 2023

What to do when genetic tests reveal links to cardiovascular disease: Scientific statement

By Elissa Wolfson

Increased use of genetic testing means people may discover they have a genetic abnormality, or gene variant, associated with cardiovascular disease.

March 27, 2023

ApoB testing may reveal patients at risk of heart disease missed by cholesterol tests: study

By Nick Paul Taylor

In the study, investigators looked at electronic medical records for patients who had ApoB and standard lipid profiles tested within 90 days of each other from 2010 to early 2022.

March 6, 2023

Heart problems more likely among long COVID patients in comprehensive study

By Elissa Wolfson

In the study, investigators found that individuals who experienced long COVID had more than double the risk of developing new cardiovascular symptoms.

February 23, 2023

Measuring NT-proBNP changes over time may improve risk stratification for heart patients

By Elissa Wolfson

Measuring the changes in the heart hormone precursor N-terminal-pro hormone BNP over time may improve risk stratification and health outcomes for heart patients.

February 8, 2023

Sepsis increases heart failure, rehospitalization risks following hospital discharge

By Elissa Wolfson

Hospital patients who initially had or developed sepsis were at higher risk for heart failure, rehospitalization, or death within 12 years than patients without sepsis.

February 1, 2023

Jana Care, Roche to develop blood-testing platform for chronic kidney and heart disease

By LabPulse.com staff writers

The platform would enable patients to self-administer critical blood tests at home, and allow clinicians to review the test results remotely.

January 31, 2023

Cardiovascular disease deaths undergo largest single-year increase since 2015

By Elissa Wolfson

Age-adjusted mortality rates also increased for the first time in many years, by a substantial 4.6%, indicating a global situation in which people of all ages were impacted by the COVID-19 pandemic, especially before vaccines became available.

January 25, 2023

Prevencio obtains Medicare pricing for three AI-enabled cardiac blood tests

By LabPulse.com staff writers

The payment rates went into effect on January 1 with Current Procedural Terminology (CPT) billing codes.

January 11, 2023

Daxor announces results of study showing benefits of blood test for measuring blood volume in heart failure

By LabPulse.com staff writers

The study showed a consistent lack of correlation between pulmonary artery diastolic pressure and total blood volume, highlighting the need for accurate volume measurement to provide a complete assessment in guiding clinical management decisions.

January 3, 2023

Natera supports guideline proposing donor-derived cfDNA testing for heart transplant surveillance

By LabPulse.com staff writers

The International Society for Heart and Lung Transplantation proposes monitoring for rejection with noninvasive biomarkers or biopsy monthly during the first six months post-transplant, as well as testing in the ninth and 12th months post-transplant.

December 23, 2022

Study reveals biomarkers associated with immune checkpoint inhibitor myocarditis

By Maryam Payne

Myocarditis during cancer treatment with an immune checkpoint inhibitor (ICI) was associated with increased levels of three biomarkers implicated in skeletal muscle damage.

December 21, 2022

Previous Page

Page 3 of 8

Next Page